Summary
For Year 2026-27, Infinium Pharmachem reports the following shareholding: Total Promoters at 64.91%, Mutual Fund at 0%, Insurance at 0%, Foreign Institutional Investors at 0%, Domestic Institutional Investors at 0.21%, and Retail at 34.87%. This breakdown provides a quick snapshot of ownership distribution for Infinium Pharmachem in 2026-27.
Infinium Pharmachem FAQs
As of 04-2026, the promoter shareholding in Infinium Pharmachem stands at 64.91% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.
The FII and DII shareholding of Infinium Pharmachem is 0% and 0.21% respectively.
The retail shareholding of the Infinium Pharmachem is 34.87%.
Changes in shareholding patterns of Infinium Pharmachem can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.
Shareholding patterns of Infinium Pharmachem are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.
The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.
